| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Friday - Mar 03, 2023 |
|||||||||
|
First Mid Bancshares
FMBH
|
- | $1.01 | - | $77.61M | - |
NASDAQ |
|||
|
inTEST
INTT
|
Q4 FY22 | $0.34 | $0.32 | $32.41M | $31.45M |
AMEX |
|||
|
OFS Capital
OFS
|
Q4 FY22 | $0.35 | $0.33 | $8.61M | $14.09M |
NASDAQ |
|||
|
Tri-Continental
TY
|
- | $0.45 | - | $11.47M | - |
NYSE |
|||
|
Stereotaxis
STXS
|
Q4 FY22 | -$0.06 | -$0.06 | $7.30M | $8.50M |
AMEX |
|||
|
Rapid Micro Biosystems
RPID
|
Q4 FY22 | -$0.39 | -$0.38 | $4.37M | $4.13M |
NASDAQ |
|||
|
Accelerate Diagnostics
AXDX
|
- | -$1.91 | - | $2.96M | - |
NASDAQ |
|||
|
Keros Therapeutics
KROS
|
- | -$1.09 | -$1.12 | - | $1.20M |
NASDAQ |
|||
